PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34552824-6	2021	The high expression of APOBEC3B indicated inferior overall survival (OS, P < .001 and P = .003) and disease-free survival (DFS, P < .001 and P < .001), yet superior therapeutic responsiveness to fluorouracil-based adjuvant chemotherapy (ACT) in TNM stage II patients.	Fluorouracil	195-207	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	Homo sapiens	23-31	
33323971-4	2021	Here, we investigate A3B expression upon treatment with chemotherapeutic drugs that activate p53, including 5-fluorouracil, etoposide and cisplatin.	Fluorouracil	108-122	apolipoprotein B mRNA editing enzyme catalytic subunit 3B	Homo sapiens	21-24